Use of Iterative Reconstruction Method in Ultralow-dose CT for Follow-up of Patients With Intraabdominal Abscess: Comparison With Standard Dose CT

Overview

Increasing radiation exposure by medical examinations is getting more concerns. For optimal medical imaging, reducing radiation exposure with preservation image quality is important. One of the solutions is use of iterative recontruction of CT examination. In this study, the investigators aimed to investigate the clinical feasibility of ultralow dose abdominopelvic CT with iterative reconstruction in patients with intraabdominal abscess. Patients with intrabdominal abscess usually undergo multiple CT examinations to evaluate treatment response. Therefore, ultralow dose CT can reduce unnecessary radiation exposure in these patients.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: March 18, 2019

Interventions

  • Other: ultralow dose abdominopelvic CT
    • In the patient cohort with abdominal abscess, ultralow dose abdominopelvic CT will be performed as a follow-up protocol. Ultralow dose CT has approximately 80~90% reduced radiation dose compared to standard dose CT.

Arms, Groups and Cohorts

  • Abscess
    • Patients group with abdominal abscess

Clinical Trial Outcome Measures

Primary Measures

  • Score of subjective image quality of CT image
    • Time Frame: 1 month
    • Score of subjective image quality of CT images consists of overall subjective image quality, noise, diagnostic ability, and artifact.

Secondary Measures

  • Effective radiation dose: CTDIvol(volume CT dose index), DLP(dose length product), effective dose(DLPx0.015)
    • Time Frame: 1 month
    • Effective radiation dose between standard dose CT and ultra-low dose CT will be compared

Participating in This Clinical Trial

Inclusion Criteria

1. patients who underwent standard dose CT for suspected intraabdominal abscess 2. patients who need follow-up CT to evaluate treatment response of abscess 3) Adult patient, 4) patients who agreed this study protocol Exclusion Criteria:

1. pregnancy 2. patients with poor renal function (GFR < 30 mL/min/1/73m2) 3. Patients who have allergy to CT contrast media 4. Patients who are not cooperative (e.g., dementia)

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: 100 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Yonsei University
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.